We provide you with the best medicine purchasing service

Quickly morph client-centric results through performance based applications. Proactively facilitate professional human capital for cutting-edge.

Download Now

img

Cysteamine hydrochloride (Cystoran®)

Cystinosis

0.55% solution with benzalkonium chloride 0.01% as a preservative: 10-12 times/day in each eye (53, 54).

Ophthalmic drops

Eyes

Neurologic: Headache (greater than or equal to 10%).
Ophthalmic: Eye irritation, Pain in eye, Photophobia (greater than or equal to 10% ), Red eye (greater than or equal to 10% ), Visual field defect (greater than or equal to 10%).

1b

53. Christodoulou J, Danks DM, Sarkar B, et al. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. American journal of medical genetics 1998;76(2):154-64

54. Sarkar B, Lingertat-Walsh K, Clarke JT. Copper-histidine therapy for Menkes disease. J Pediatr 1993;123(5):828-30

footer shape